Chemomab Therapeutics Ltd - ADR (CMMB) is around the middle of the Biotechnology industry according to InvestorsObserver. CMMB received an overall rating of 40, which means that it scores higher than 40 percent of all stocks. Chemomab Therapeutics Ltd - ADR also achieved a score of 39 in the Biotechnology industry, putting it above 39 percent of Biotechnology stocks. Biotechnology is ranked 50 out of the 148 industries.
CMMB has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on CMMB!